Acurx Pharmaceuticals, INC.
biopharmaceutical company
Based in NY
AI Overview
With $130K in lobbying spend across 6 quarterly filings, Acurx Pharmaceuticals, INC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2024 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2024 | $20K |
| 2025 | $110K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Acurx Pharmaceuticals, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Defense
Research and clinical trials for the development of antibiotics for infections caused by bacteria listed as priority pathogens.
H.R.____/S.____, Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations bill, 2026, Title II, all provisions related to research and clinical trials for the de
H.R.____/S.____, Department of Defense Appropriations Bill, 2026, Title IV, all provisions related to biodefense preparedness. H.R.____/S.____, Departments of Labor, Health and Human Services, Educati
H.R.4026/S.____, Department of Defense Appropriations Bill, 2026, Title IV, all provisions related to biodefense preparedness. H.R.____/S.____, Departments of Labor, Health and Human Services, Educati
H.R.____/S.2296, National Defense Authorization Act, 2026, Title II, all provisions related to biodefense preparedness.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.